Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
Clinical trial NCT03939962 · UNKNOWN
Trial details
- NCT number
- NCT03939962
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2021-05-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.